US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 516.740
  • +14.290+2.84%
Close Nov 8 16:00 ET
  • 516.910
  • +0.170+0.03%
Post 20:01 ET
133.08BMarket Cap-271968P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.69B
2.77B
+81.58M
Beat Est.
+8.33%
+11.61%
+3.03%
EPS
3.63
4.01
+0.38
Beat Est.
-8.55%
+1.01%
+10.45%
Analyst Rating
Buy

Nov 9, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 2.799B --
-- 2024/Q4 -- / 2.783B --
Nov 4, 2024 2024/Q3 2.772B / 2.690B --
Aug 1, 2024 2024/Q2 2.646B / 2.665B --
-- 2024/Q1 2.691B / 2.580B --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.799B--
--2024/Q4-- / 2.783B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6 05:17

  • Vertex Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 3 04:06

  • Vertex Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 04:50

  • Vertex Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 16 05:20

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 9, 2024

    Buy

    • Buy

      60.71%

    • Hold

      32.14%

    • Sell

      7.14%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Gene Editing
    Gene Editing
    Intraday+1.71%